Diabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohort.

Rachel Dankner; Ran Balicer; Paolo Boffetta; Lital Keinan Boker; Sylvan Wallenstein; Laurence Freedman; Margalit Goldfracht; Jesse Roth; Ronald Tamler; Derek LeRoith

doi:10.1186/1471-2407-12-364

Diabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohort.

Identifier:nobleid.org/w1/20260515/F9DA881F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F9DA881F.svg?ark=w1%2F20260515%2FF9DA881F)](https://nobleid.org/work/w1/20260515/F9DA881F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Diabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohort.

Identifier:nobleid.org/w1/20260515/F9DA881F

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F9DA881F.svg?ark=w1%2F20260515%2FF9DA881F)](https://nobleid.org/work/w1/20260515/F9DA881F)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work